rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Andrew James Norstrud

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Upexi; CFO, nDivision; CFO, GEE Group; Chief Financial Officer, Jagged Peak; Chief Financial Officer, Stem Cell Therapy International.

In numbers

Trades disclosed
23
Buys
6
Sells
0
Bought
$121K
Sold
$0
Companies
5
Companies where not an officer
0
First trade
29 Dec 2005
Last trade
3 Jul 2026
Last filed
20 Jul 2026

Companies traded

Where they are an officer
UPXI UpexiDirector, Officer · Digital Asset Treasuries · last 3 Jul 20261 buy · 0 sells
nDivisionDirector, Officer · last 22 Dec 20210 buys · 0 sells
JOB GEE GroupDirector, Officer · Professional Services · last 23 Jul 20151 buy · 0 sells
Jagged PeakOfficer · last 9 May 20114 buys · 0 sells
Stem Cell Therapy InternationalDirector, Officer · last 4 Jan 20100 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
3 Jul 2026filed 20 Jul 2026UPXI UpexiDigital Asset TreasuriesSEC FORM 4 Code A—400,000 at $0.00filing
3 Jul 2026filed 20 Jul 2026UPXI UpexiDigital Asset TreasuriesSEC FORM 4 Code A—400,000 at $0.00filing
1 Oct 2025filed 21 Nov 2025UPXI UpexiDigital Asset TreasuriesSEC FORM 4 Code A—240,000 at $0.00filing
16 Jul 2025filed 24 Jul 2025UPXI UpexiDigital Asset TreasuriesSEC FORM 4 Code A—250,000 at $0.00filing
17 Apr 2025filed 25 Apr 2025UPXI UpexiDigital Asset TreasuriesSEC FORM 4 Bought$100K43,860 at $2.28filing
17 Apr 2025filed 25 Apr 2025UPXI UpexiDigital Asset TreasuriesSEC FORM 4 Code A—100,000 at $0.00filing
22 Dec 2021filed 28 Dec 2021nDivisionoption or derivativeSEC FORM 4 Code J$19K100,000 at $0.19filing
21 Jul 2021filed 30 Aug 2021UPXI Upexioption or derivative · Digital Asset TreasuriesSEC FORM 4 Code A—200,000filing
22 Aug 2018filed 9 Apr 2019nDivisionoption or derivativeSEC FORM 4 Code A$13K20,000 at $0.63filing
23 Jul 2015filed 28 Jul 2015JOB GEE Groupoption or derivative · Professional ServicesSEC FORM 4 Code A$210K300,000 at $0.70filing
25 Mar 2014filed 26 Mar 2014JOB GEE GroupProfessional ServicesSEC FORM 4 Bought$11K50,000 at $0.22filing
7 Mar 2014filed 11 Mar 2014JOB GEE Groupoption or derivative · Professional ServicesSEC FORM 4 Code A—1,000,000 at $0.00filing
28 Jan 2014filed 10 Feb 2014JOB GEE Groupoption or derivative · Professional ServicesSEC FORM 4 Code A—200,000 at $0.00filing
9 May 2011filed 10 Aug 2011Jagged Peakoption or derivativeSEC FORM 4 Code A$52K400,000 at $0.13filing
4 Jan 2010filed 16 Feb 2010Stem Cell Therapy Internationaloption or derivativeSEC FORM 4 Code A$55K500,000 at $0.11filing
4 Sep 2009filed 9 Sep 2009Stem Cell Therapy Internationaloption or derivativeSEC FORM 4 Code A$36K900,000 at $0.04filing
27 Jul 2009filed 9 Sep 2009Stem Cell Therapy InternationalSEC FORM 4 Code A$60K1,000,000 at $0.06filing
19 Dec 2007filed 19 Dec 2007Jagged PeakSEC FORM 4 Bought$3,00010,000 at $0.30filing
14 Dec 2007filed 19 Dec 2007Jagged PeakSEC FORM 4 Bought$1,5005,000 at $0.30filing
7 Dec 2007filed 7 Dec 2007Jagged PeakSEC FORM 4 Bought$3,00015,000 at $0.20filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Digital Assets1
Industrials1
Not placed4

Buys in green, sells in red, by the company’s sector.

Related people

Gene SalkindDirector · Director at Upexi, filing Form 4 there in the last year
Allan MarshallChief Executive Officer · Chief Executive Officer at Upexi, filing Form 4 there in the last year
Lawrence DuganDirector · Director at Upexi, filing Form 4 there in the last year
Brian Benjamin RudickChief Strategy Officer · Chief Strategy Officer at Upexi, filing Form 4 there in the last year
Kim D. ThorpeSenior Vice President, CFO · Senior Vice President, CFO at GEE Group, filing Form 4 there in the last year